Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor microenvironment in salivary gland carcinomas: An orchestrated state of chaos.
Egal ESA, Scarini JF, de Lima-Souza RA, Lavareze L, Fernandes PM, Emerick C, Gonçalves MT, Helms MN, Altemani A, Mariano FV. Egal ESA, et al. Among authors: emerick c. Oral Oncol. 2022 Apr;127:105777. doi: 10.1016/j.oraloncology.2022.105777. Epub 2022 Feb 18. Oral Oncol. 2022. PMID: 35189584 Free article. Review.
Discovery proteomics reveals potential protein signature associated with malignant phenotype acquisition in pleomorphic adenoma.
de Lima-Souza RA, Scarini JF, Lavareze L, Emerick C, Crescencio LR, Domingues RR, Paes Leme AF, Mariz BALA, Bastos DC, Machado RA, Tincani AJ, Del Negro A, Chone CT, Kowalski LP, Egal ESA, Altemani A, Mariano FV. de Lima-Souza RA, et al. Among authors: emerick c. Oral Dis. 2023 Apr;29(3):1017-1027. doi: 10.1111/odi.14102. Epub 2022 Jan 23. Oral Dis. 2023. PMID: 34902207
Spotlight on rare cancers.
Emerick C, Mariano FV, Squarize CH, Castilho RM. Emerick C, et al. Oral Dis. 2024 Mar;30(2):799-800. doi: 10.1111/odi.14284. Epub 2022 Jun 26. Oral Dis. 2024. PMID: 35719113 No abstract available.
Head and neck squamous cell carcinoma: Exploring frontiers of combinatorial approaches with tyrosine kinase inhibitors and immune checkpoint therapy.
Scarini JF, Lavareze L, de Lima-Souza RA, Emerick C, Gonçalves MT, Figueiredo-Maciel T, Vieira GS, Kimura TC, de Sá RS, Aquino IG, Fernandes PM, Kowalski LP, Altemani A, Mariano FV, Egal ESA. Scarini JF, et al. Among authors: emerick c. Crit Rev Oncol Hematol. 2022 Dec;180:103863. doi: 10.1016/j.critrevonc.2022.103863. Epub 2022 Nov 2. Crit Rev Oncol Hematol. 2022. PMID: 36334881 Review.
25 results